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Introduction: Non-adherence to daily controller medication in childhood asthma is strongly dependent
on potentially modifiable factors such as parental illness perceptions and medication beliefs. The extent
to which adherence in children can be improved by addressing modifiable determinants of non-
adherence has not been studied to date, however. We assessed long-term adherence and its de-
terminants in children with asthma enrolled in a comprehensive asthma care program employing shared
decision making with parents.
Methods: Observational study in 135 children 2e12 years of age with asthma attending a hospital-based
outpatient clinic. One-year adherence to inhaled corticosteroids was measured by electronic devices.
Parental illness perceptions and medication beliefs, and asthma control were assessed by validated
questionnaires.
Results: Median (interquartile range) adherence was 84% (70e92%). 55 children (41%) did not achieve the
pre-defined level of good adherence (80%) and this was associated with poorer asthma control. Parental
perceived medication necessity was high, with a median (interquartile range) BMQ necessity score of 17
(16e20). Parents' replies to the five key questions on the core issues of the program showed high
concordance of their illness perceptions and medication beliefs with the medical model of asthma and its
treatment. Differences in these perceptions between adherent and non-adherent families were small and
non-significant.
Conclusions: Poor adherence may persist in children despite a high level of concordance between
medical team and parents on illness perceptions and medication beliefs, even in the absence of socio-
economic barriers to good adherence. Achieving good adherence in all children is a complex task,
requiring interventions not covered in current guidelines of managing asthma in children.
© 2015 Elsevier Ltd. All rights reserved.1. Introduction
Adherence to daily medication is of critical importance in
determining the success of treating chronic conditions such as
childhood asthma [1e3]. Poor adherence to maintenance medica-
tion is the rule rather than the exception, however [2,4]. This may419.0, 3508 AB, Utrecht, The
Klok), a.a.kaptein@lumc.nl
erman), p.l.p.brand@isala.nlbe the result of patients and their parents not understanding the
rationale for treatment (unwitting non-adherence) [5,6], which
should be remediable by health care professionals providing in-
formation on the mechanisms of disease, the beneficial effects of
medication, and the importance of daily use of controller medica-
tion. Studies, however, have shown that such education alone is
insufficient to improve adherence [4,7], indicating that other fac-
tors aremore important in driving non-adherence. These have been
divided into two groups. Unplanned non-adherence relates to
disorganized family (medicine taking) routines and child raising
issues [6,8,9], and intentional non-adherence refers to patients (or
their parents) who deliberately choose not to follow the doctor's
T. Klok et al. / Respiratory Medicine 109 (2015) 1114e1119 1115recommendations [5,6]. Intentional non-adherence, strongly
driven by illness perceptions and medication beliefs, has been
proposed as the most important form of non-adherence, both in
qualitative and quantitative studies [10,11].
Because of the accumulating evidence on the behaviors
responsible for medication taking, non-adherence is now increas-
ingly being viewed as ‘a condition that can be diagnosed and
treated’ [12]. The extent to which adherence in children can be
improved by addressing modifiable determinants of non-
adherence has not been studied to date, however. If parental
illness perceptions and medication beliefs are indeed the strongest
determinants of adherence, excellent adherence should be ex-
pected in patients whose parents express beliefs concordant to the
medical model of asthma.
We previously reported a very high median level of adherence
to inhaled corticosteroids (ICS) over 3 months in 2e6 year old
childrenwith asthma enrolled in a comprehensive, guideline-based
asthma management program [13]. Even in this group with high
median adherence levels, the degree of adherence was strongly
related to medication beliefs [13].
The aim of the present study was to assess one-year adherence
to ICS and its determinants in 2e12 year old children with asthma.
We focused on the role of illness perceptions and medication be-
liefs, hypothesizing that these would be different between families
with high and those with lower levels of adherence.
2. Methods
2.1. Design and setting
This was an observational study with one year follow-up of
asthmatic children aged 2e12 years, receiving asthma care in our
hospital-based outpatient center with comprehensive self-
management education and close follow-up. Details of our
asthma management program have been described previously
[13,14]. Briefly, children with troublesome or difficult to control
asthma symptoms can be referred to our center by their primary
care physician (which, in the Netherlands, is always a family
physician). Our center is situated in a large secondary care general
teaching hospital serving a mixed urban-rural population of
approximately 350,000 inhabitants. Our strategy is to reach
consensus with patients and parents on the treatment plan
including daily use of ICS controller therapy through shared deci-
sion making [15]. We aim to achieve this by providing compre-
hensive self-management education and counseling, specifically
eliciting, addressing and discussing parental illness perceptions
and medication beliefs, instructing and checking correct inhalation
technique, and providing scheduled close follow-up, with low-
threshold accessibility to both pediatricians and asthma nurses
for questions, concerns, and check-ups [14,15]. All children referred
to our center in whom the diagnosis of persistent asthma is made
are being prescribed daily ICS therapy. Patients are being seen at the
center at least quarterly during the first year of the program, and at
least twice a year afterwards (at least once a year by the attending
pediatrician, and at least once a year by the pediatric asthma nurse).
2.2. Inclusion
Inclusion criteria for this studywere a diagnosis of asthmamade
by the attending pediatrician based on national Dutch guidelines
for the diagnosis and management of asthma (which are compa-
rable to international guidelines) [16], and use of ICS for at least
three months. Exclusion criteria comprised limited knowledge of
the Dutch language, severe comorbidity and a sibling participating
in the study.Over a one-year period, parents of all 2e12 year old children
with asthma visiting our outpatient clinic for a scheduled follow-up
visit were asked to participate in the study. We aimed to include at
least 100 patients to allowanalysis of determinants of adherence, as
a representative sample of all patients visiting our hospital-based
secondary care pediatric asthma clinic, as previously reported [13].
2.3. Follow-up and assessment of adherence to ICS
Throughout the 12-months follow-up, adherence was moni-
tored by electronic devices logging date and time of each ICS
actuation: Smartinhaler® for MDI/spacer combination, Smart-
Tracker® for MDI with dose counter, and SmartDisk® for Diskus/
Accuhaler [13,17]. At each follow-up visit, or during home visits
when time to the next scheduled follow-up visit exceeded 5
months, data recorded by the electronic devices where uploaded
and proper recording function checked. Adherence was calculated
as the number of electronically recorded inhaled doses expressed
as a percentage of the number of doses prescribed, censored at
100% of the prescribed dose. Adherence data were not fed back to
patients and parents, and remained unknown to the attending
physician. To assess physicians' ability to recognize their non-
adherent patients, the attending pediatrician was requested at
each follow-up visit to estimate the patient's adherence on a visual
analogue scale ranging from 0% to 100%. The primary investigator
(TK) was the only personwith access to the adherence data, and he
was not involved in the medical care of study patients.
2.4. Putative determinants of adherence
We collected information on a range of putative determinants of
adherence in all participating children. A complete list of these
determinants is presented in e-Table 1 in the online repository.
Briefly, the following determinants were assessed.
- Clinical and demographic data were collected by structured
interview and chart review. At baseline, lung function was
assessed before and after inhaling salbutamol 400 mg: flow-
evolume curves in children 5 years of age and older, and res-
piratory resistance (Rint) by MicrorintR in children < 5 years of
age (MicrorintR; Micro Medical Ltd, Rochester, UK), following
international guidelines [18,19]. Results were expressed as Z-
scores [20].
- Parental illness perceptions and medication beliefs were assessed
upon entry into the study by a number of validated question-
naires: the Brief Illness Perception Questionnaire (B-IPQ) [21],
the Beliefs about Medicines Questionnaire (BMQ) [22], and the
Treatment Satisfaction Questionnaire for Medication (TSQM)
[23]. In addition, we applied the ‘I Worry scale’ (scoring parental
worries about their child having asthma and using daily ICS)
[24], and a locally developed asthma knowledge questionnaire
to assess parental knowledge about the use of medication. The
BMQ consists of 10 questions measured on a 5-point Likert-
scale, five on necessity and five on concerns about ICS (sum
scores of both items 5 to 25). The balance between these parent-
perceived necessity and concerns can be calculated by sub-
tracting the individuals' concerns score from the individuals'
necessity score leading to a range of 20 to 20. Higher scores
indicate stronger perceived necessity and/or lower concerns
towards ICS use.
- To assess the effectiveness of our asthma self-management pro-
gram and the achieved concordance with parents through shared
decision making, the members of our asthma team a priori
identified the five key questions from these questionnaires
reflecting the core issues of the program (Table 2). Parents
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agreement with the medical model of asthma presented in our
self-management education program were considered to show
optimal concordance with the medical team.
- Childrens' illness perceptions andmedication beliefswere assessed
in participating children aged 8e12 years, who completed
children's versions of each questionnaire, without input from
their parents, under supervision of the investigator (TK).
- Quality of asthma care: we asked the parents to assess the degree
of patient centeredness the physician had employed during the
study periodwith a previously published questionnaire focusing
on physician's exploration of parental views and concerns about
the illness and the medication and on achieving mutual agree-
ment about treatment [25]. In addition parents completed the
Satisfactionwith Information about Medicines Scale (SIMS) [26].
- At baseline and after 6 and 12 months of follow-up, asthma
control and parental quality of life were assessed by parent-
completed Asthma Control Questionnaire (ACQ) and the Pedi-
atric Asthma Caregiver Quality Of Life questionnaire (PACQOL),
respectively [27,28].
2.5. Analysis
We assessed the association of ICS adherence to all putative
determinants, as defined a priori with a focus on parental percep-
tions about illness and medication, and on concordance between
parents and medical team on the core issues of the program.
Adherence was analyzed both as a continuous variable and
dichotomized as good (80%) and poor (<80%) adherence because
previous studies have shown that adherence > 80% is associated
with good asthma control [1,2]. Because the distribution of adher-
ence was highly skewed, nonparametric analyses were used
throughout. The relationship of adherence to determinants with an
ordinal distribution was assessed by Spearman's rank correlation
coefficient (r), and its association to binary determinants with the
ManneWhitney U test. Additional analyses of the relationship be-
tween determinants and adherence were performed after adher-
ence was dichotomized as >80% (good adherence) or < 80% (poor
adherence). The relationship of dichotomized adherence to de-
terminants with an ordinal distribution was assessed by the Man-
neWhitney U test, and its association to binary determinants with
the Fisher's exact test.
We chose to refrain from adjustments for multiple comparisons
and from multivariate analysis because of the exploratory and
observational nature of our study. All analyses were performed
using SPSS version 17.0.
2.6. Ethical considerations
This study was approved by the hospital ethics review board; all
parents provided written informed consent.
3. Results
3.1. Patient recruitment and follow-up
The recruitment and follow-up of children is presented sche-
matically in Fig. 1. The 135 children recruited for long-term
adherence monitoring were similar to the root population of
eligible patients in demographic and clinical characteristics (data
not shown). Of the 135 children (92% of those enrolled) who
completed the study, 125 (93%) were followed for 1 year. In the
remaining 10 children, ICS were stopped by mutual agreement
between pediatrician and parents because the child was in
apparent clinical remission (complete asthma control without theneed for on-demand bronchodilator use, no exacerbations and no
limitations in activities of daily life, sports and play for at least 12
months). For these patients, adherence datawere being used if they
had participated for at least 3 months in the study (Fig. 1).
Clinical and demographic characteristics are presented in
Table 1. This was, on average, a middle-class Caucasian population.
Most children had well-controlled asthma during maintenance
treatment with only low-to moderate-dose ICS (Table 1). 15 pa-
tients (11%) had an exacerbation requiring a course of oral corti-
costeroids, two of whom (1.5% of total population) were
hospitalized for asthma during the study period.
3.2. Adherence rates
Overall adherence was high, with median (interquartile range,
IQR) adherence of 84% (70e92%). Of the 55 children (41%) with poor
adherence (<80%), 21 (16% of the study population) had overall
adherence < 50% of prescribed doses. Twenty-seven children (20%)
received no ICS on  20% of study days. The attending physicians
estimated an adherence level below 80% in 25 (45%) of the 55
childrenwith poor adherence and in 9 (11%) of the 80 childrenwith
good adherence.
3.3. Parental illness perceptions and medication beliefs
Parental perceived ICS necessity was high, with a median (IQR)
BMQ necessity score of 17 (16e20). ICS concerns exceeded neces-
sity in 5 families (6%) with good adherence and 5 families (9%) with
poor adherence (p ¼ 0.740). The median (IQR) necessity-concerns
differential was 5.5 (3.2e10.8). Parents who viewed daily ICS
administration as convenient, and who expected little harm of
medicines in general had higher ICS adherence rates (rank corre-
lation coefficient between independent variables and adherence
0.26 [p ¼ 0.003] and 0.19 [p ¼ 0.031], respectively). None of the
other items in the questionnaires showed statistically significant
differences in parental perceptions and beliefs between adherent
and non-adherent families.
Parents' replies to the five key questions on the core issues of the
program showed high concordance of their illness perceptions and
medication beliefs with the medical model of asthma and its
treatment. Differences in these perceptions between adherent and
non-adherent families were small and almost universally non-
significant (Table 2). Forty-eight non-adherent families (87%) had
illness perceptions and medication beliefs concordant with the
medical model of asthma (Table 2).
3.4. Determinants of adherence
Of all other putative determinants of adherence, only better
asthma control at 12 months follow-up as assessed by the ACQ was
statistically significantly related to higher adherence (both when
analyzed as a continuous variable and dichotomized as good
(80%) and poor (<80%) adherence). Asthma control at study entry
and at 6 months was also related to adherence. In the 28 completed
questionnaires by children aged 8e12 years, only children's global
satisfaction of daily ICS use was related to adherence when
analyzed as a continuous variable (r ¼ 0.51, p ¼ 0.006). No other
characteristics of children, including age, were related to
adherence.
4. Discussion
In this cohort of children with asthma receiving comprehensive
asthma care, we recorded a high median adherence to ICS of 84% of
prescribed doses. Their parents, mostly from Caucasian middle
Table 1
Characteristics of study patients, their parents and parental assessment of asthma care (n ¼ 135).
Patients
Age (mean; range; yrs) 6 (2e12)
Maintenance medication: -inhaled corticosteroids (ICS) 90%
-ICS and long-acting bronchodilators (%) 10%
-ICS dose (fluticasone®; mean; range; mg) 250 (125e500)
Nr of children hospitalized in year before study (%) 37 (27%)
ACQ baseline (<0.75 ¼ well-controlled asthma, >1.5 ¼ not well-controlled asthma) 0.50 (0. 17e1.17)
ACQ at 6 months (n ¼ 122) 0.33 (0 .00e1.00)
ACQ at 12 months (n ¼ 107) 0.50 (0 .00e1.17)
Positive specific IgE to common inhalant allergens (%, n ¼ 126) 61%
FEV1 baseline (z-score, n ¼ 79) 0.27 ± 1.2
Rint baseline (z-score, n ¼ 33) 1.90 ± 2.8
Parents
Educational level of mother (1 ¼ low and 7 ¼ high, n ¼ 131) 5 (5e6)
Parental diagnosis of asthma (n ¼ 133) 40%
Smoking (n ¼ 133) 30%
PACQOL (1 ¼ low and 7 ¼ high quality of life) 6.3 (5.5 to 6.9)
PACQOL at 6 months (n ¼ 118) 6.7 (6.1e6.9)
PACQOL at 12 months (n ¼ 105) 6.7 (6.3e6.9)
Asthma care
Duration of outpatient clinic asthma care before study (months) 18 (8e36)
Scheduled visits to outpatient clinic in year before study 4 (3e6)
SIMS (0 ¼ low and 9 ¼ high level of satisfaction) 9 (7e9)
Patient-centeredness questionnaire (1 ¼ low and 5 ¼ high, n ¼ 107) 4.0 (3.4e4.6)
Data are presented as mean ± SD, or as median (interquartile range) unless otherwise stated; ACQ: Asthma Control Questionnaire [28]; Ig: immunoglobin; FEV1: forced
expiratory volume in 1 s; Rint: respiratory resistance by the interrupter technique; PACQOL: pediatric asthma caregiver quality of life questionnaire [27]; SIMS: Satisfaction
with Information about Medicines Scale [26].
Table 2
Key questions from the applied questionnaires, reflecting core educational aims of the self-management team and the level of achieved concordance.
Scorea and % concordanceb of
parents with adherence >80%
Score and % concordance of
parents with adherence <80%
p-value
BMQ: 1 strongly agree e 5 strongly disagree
My child's health at present, depends on the medicines 2 (2e2) 92% 2 (2e2) 76% 0004
My child's medicines protect him/her from becoming worse 2 (1e2) 96% 2 (2e2) 89% 0223
Brief IPQ: 1 not at all e 10 extremely helpful
How much do you think the treatment can help your child's illness 8 (8e9) 94% 8 (7e9) 93% 0040
Asthma knowledge questionnaire: 1 ¼ true, 2 ¼ false, 3 ¼ I don't know
My child needs medication only when having symptoms. 2 (2e2) 96% 2 (2e2) 95% 0397
TSQM: 1 ¼ Extremely satisfied e 7 ¼ Extremely dissatisfied
Overall, how confident are you that taking this medication is a good
thing for your child?
2 (1e2) 92% 2 (1e3) 82% 0075
≥ 4 of the 5 parental replies concordant with the asthma team (%) 92% 87% 0337
BMQ: Beliefs about medicines questionnaire [22]; IPQ: Illness perceptions questionnaire-brief version [21]; TSQM: Treatment Satisfaction Questionnaire for Medication [23].
a Score presented as median and inter quartile range.
b Concordance defined as parental answers in agreement with the self-management education.
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(agreement with themedical team on the necessity of daily ICS use)
was achieved with most parents. Despite the high median adher-
ence rate and the high level of concordance, 55 children (40%) in
our study failed to achieve the predefined threshold for good
adherence of 80%, of whom only 25 children (45%) were correctly
identified by their attending physician as non-adherent. Children
with poor adherence had lower levels of asthma control. Adherence
was not associated with the child's age.4.1. High median adherence
To our knowledge, this study reports the highest long-term
adherence rate ever recorded in children or adults. Previous
adherence studies using electronic measurement of daily ICS use in
childrenwith asthma reported adherence rates ranging from 34% to
77% [2]. No study assessing adherence for a time period of more
than 6 months ever reported adherence levels exceeding 60% [2].
The most likely cause for the exceptionally high adherence rate we
observed is the focus on achieving concordance with parents in ourcomprehensive asthma program through shared decision making.
In addition, the prevalence of other known barriers to adherence,
such as poverty and poor access to health care, was low in our study
population. Remarkably, despite the high overall adherence, 40% of
the study population showed poor adherence associated with
lower levels of asthma control [1,13].4.2. Illness perceptions and medication beliefs
A considerable body of evidence from a wide range of chronic
conditions in adults and children shows that illness perceptions
and medication beliefs are the strongest determinants of (non)-
adherence to long-term therapy [10]. A previous Dutch study
showed high prevalence of concerns about long-term ICS use in
children with asthma, outweighing the perceived necessity of daily
ICS use in many children [29]. This was also found in a previous
focus group study among parents of children with asthma treated
in primary care practices referring their patients to our outpatient
clinic [30]. Apparently, most parents of asthmatic children have
illness perceptions about asthma and medication beliefs about its
202 eligible children 
Parents of 198 
children reached by 
telephone
147 children 
included in 1 yr 
follow-up study
Follow-up of 135 
children
Parents of 4 children not reached by 
telephone
12 children lost to follow up:
- ICS withdrawn before 3 month follow-up
- moved to other area
- technical failure of monitoring device
- parents stopped par?cipa?on
Parents of 44 children declined 
par?cipa?on
Parents of 7 children had limited knowledge 
of Dutch language
Exclusion of 30 children:
- 4 siblings of children included previously 
- 8 children with severe comorbidity




Fig. 1. patient flow chart.
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expressed in asthma guidelines. By contrast, the large majority of
parents in our study expressed illness perceptions and medication
beliefs in agreement with this medical model of asthma, with ICS
necessity exceeding concerns in 91% of parents. We previously
argued that this is likely to be the result of our comprehensive
asthma care program focusing on achieving concordance with
parents through shared decision making [13,30]. Interestingly,
however, such illness perceptions and medication beliefs in
accordance with the medical model of asthma were also observed
in most parents with poor adherence in the present study. Inten-
sifying self-management education aimed at modifying parental
illness perceptions and medication beliefs is therefore unlikely to
achieve the desired improvement in adherence in the 40% of fam-
ilies with poor adherence (<80%). For these families, other barriers
of adherence need to be considered, therefore.4.3. Other modifiable determinants of adherence
Apart from illness perceptions and medication beliefs, non-
adherence may also be determined by a range of other modifiable
and non-modifiable factors [31]. Previous studies have highlighted
a number of barriers to optimal adherence including limited access
to health care, limited health insurance, illiteracy, language bar-
riers, and issues generating ‘high levels of worry about competing
household priorities’, such as poverty [31,32]. These did not appear
to play a role in our study population which was, on average,
middle class, with good access to health care, mandatory health
insurance covering reimbursement of maintenancemedication use,
and proper understanding of the Dutch language. In a previousstudy using in-depth interviews with parents whose children
showed poor adherence revealed additional barriers to adherence,
such as child-raising issues, relational issues, and transferring re-
sponsibility for daily medication use to the child at an inappro-
priately early age [33]. The present study shows that most of these
non-adherent families were not recognized by the attending
pediatrician, despite the extensive asthma care with frequent
follow-up visits. These findings suggest that identifying non-
adherence and its barriers is likely to require both actively and
objectively monitoring of adherence [2], feedback of its results [34],
and non-confrontational discussion of potential reasons for non-
adherence [15]. Whether barriers identified in such a way can be
modified through targeted interventions should be investigated in
further studies.
4.4. Strengths and weaknesses
Themain strengths of this study are the electronic assessment of
adherence and the 12-months follow-up period. The main limita-
tion of our study is its generalizability. Because most parents and
children in our study population came from Caucasianmiddle-class
families, the applicability of our findings to other social settings
remains to be established. However, because many barriers such as
limited access to health care were not prevalent in this population,
this study highlights the difficulties in achieving optimal adherence
in children with asthma and their families, even in the absence of
socio-economic disadvantages.
5. Conclusion
In this middle class Caucasian population of families with chil-
dren with asthma with good access to comprehensive asthma care,
a high level of concordance regarding the daily use of ICS was
achieved. Although this was associated with a high median
adherence of 84% of prescribed doses, 40% of the children remained
non-adherent. These children had lower levels of asthma control,
and were poorly recognized by the medical team. It is unlikely that
this type of non-adherence can be improved by additional educa-
tion or focusing on illness perceptions and medication beliefs. Po-
tential strategies required to improve adherence may need a tailor-
made approach including objective assessment of adherence and a
non-confrontational and detailed discussion of potential barriers to
adherence.
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